USA – FDA to authorise Pfizer’s Covid19 vaccine for adolescents by next week
The US Food and Drug Administration is expected to authorise Pfizer’s Covid-19 vaccine for young adults age 12 and older by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.
The announcement is set to come barely a month after the company found that its shot, which is already authorised for those age 16 and older, also provided protection for the younger group.
A potential approval of the vaccine would boost the country’s immunization drive and help allay fears of parents anxious to protect their children from COVID-19.
Pfizer and Moderna have also launched trials in even younger children, aged six months to 11 years old. Both companies have said they hope to be able to vaccinate children under 11 as soon as early 2022.